Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00193661 · ClinicalTrials.gov registry record · Phase 2
Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism
A Phase 2 study, sponsored by Solvay Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00193661 is a Phase 2 study that has completed, run by Solvay Pharmaceuticals.
The verdict
NCT00193661, a Phase 2 study, has completed, sponsored by Solvay Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty adolescents. Subjects who complete this trial may enter a 3 month extension study (UMD-01-090E).
Interventions
- DRUG Testosterone Gel (1%)
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-08 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00193661
The ClinicalTrials.gov registry entry for NCT00193661 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Solvay Pharmaceuticals, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testosterone Gel (1%) is the first listed.
NCT00193661 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00193661 about?
NCT00193661 is a clinical study titled "Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism". This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty adolescents. Subjects who complete this trial may enter a 3 month extension study (UMD-01-090E).
What is the current status of trial NCT00193661?
This trial is currently completed. It is a Phase 2 study. The study started on 2002-08. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00193661?
The interventions under investigation include: Testosterone Gel (1%) (DRUG).
Who is sponsoring clinical trial NCT00193661?
This trial is sponsored by Solvay Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.